CHONG KUN DANG PHARMACEUTICAL CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99,200 KRW | -2.36% |
|
-2.07% | -24.22% |
| Jan. 23 | Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. | CI |
| Jan. 23 | Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan. | CI |
| Sales 2024 * | 1,549B 1.13B | Sales 2025 * | 1,635B 1.19B | Capitalization | 1,260B 917M |
|---|---|---|---|---|---|
| Net income 2024 * | 88B 64.06M | Net income 2025 * | 102B 74.26M | EV / Sales 2024 * | 0.69 x |
| Net cash position 2024 * | 197B 143M | Net cash position 2025 * | 262B 191M | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
14.3
x | P/E ratio 2025 * |
12.6
x | Employees | 2,291 |
| Yield 2024 * |
0.98% | Yield 2025 * |
1% | Free-Float | 52.44% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.36% | ||
| 1 week | -2.07% | ||
| Current month | -9.98% | ||
| 1 month | -9.49% | ||
| 3 months | -8.15% | ||
| 6 months | +7.60% | ||
| Current year | -24.22% |
1 week
98 300.00
102 000.00
1 month
98 300.00116 800.00
Current year
98 300.00130 900.00
1 year
69 428.57136 500.00
3 years
66 213.15136 500.00
5 years
50 102.58236 115.61
10 years
38 518.93236 115.61
| Managers | Title | Age | Since |
|---|---|---|---|
Young-Ju Kim
CEO | Chief Executive Officer | 60 | 15-03-19 |
Jong-Rae Lim
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang-Gyu Kim
BRD | Director/Board Member | 68 | - |
Seong-Gon Kim
BRD | Director/Board Member | 62 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 7 M€ | -0.18% | - | |
| 0.00% | 117 M€ | -1.55% | - | |
| 0.00% | 7 M€ | +0.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 99,200 | -2.36% | 44,343 |
| 24-04-18 | 101,600 | +2.52% | 17,446 |
| 24-04-17 | 99,100 | -1.00% | 30,529 |
| 24-04-16 | 100,100 | +0.50% | 43,237 |
| 24-04-15 | 99,600 | -3.11% | 34,794 |
End-of-day quote Korea S.E., April 18, 2024
More quotes
Chong Kun Dang Pharmaceutical Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The company sells products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.22% | 938M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
- Stock Market
- Equities
- A185750 Stock
